Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Antitumor activity
Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats
3S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-1-[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxamide
ClH/c1-8(2)6-10(14)12(16)15-11(7-9(3)4)13(17)18-5
UL-FS-49CL
(S)-JQ-35 hylellagic acid-4'-O-β-D-glucopyranoside Antitumor activity(S) JQ 35 (TEN 010) is an inhibitor of the Bromodomain and Extra Terminal (BET) family bromodomain containing proteins with potential antineoplastic activity. Product information CAS Number: 1349719 98 7 Molecular Weight: 540. 12 Formula: C27H34ClN7OS Chemical Name: 2 [(9S) 7 (4 chlorophenyl) 4,5,13 trimethyl 3 thia 1,8,11,12 tetraazatricyclo[8. 3. 0. 0,]trideca 2(6),4,7,10,12 pentaen 9 yl] N [3 (4 methylpiperazin 1 yl)propyl]acetamide Smiles: